(Q46885968)

26 December 2017

title

Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development (English)

1 reference

26 December 2017

1 reference

Fei Huang

1

1 reference

26 December 2017

Joel C Thompson

2

1 reference

26 December 2017

Patricia G Wilson

3

1 reference

26 December 2017

Hnin H Aung

4

1 reference

26 December 2017

John C Rutledge

5

1 reference

26 December 2017

Lisa R Tannock

6

1 reference

26 December 2017

publication date

21 November 2007

1 reference

26 December 2017

Journal of Lipid Research

published in

1 reference

26 December 2017

volume

49

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

521-530

1 reference

26 December 2017

Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

The response-to-retention hypothesis of early atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Phospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Decorin links low-density lipoproteins (LDL) to collagen: a novel mechanism for retention of LDL in the atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Expression of minichromosome maintenance proteins in vascular smooth muscle cells is ERK/MAPK dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFbeta in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

TGF-beta1 and angiotensin networking in cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Proteoglycans can mediate renal lipoprotein retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Identification of the proteoglycan binding site in apolipoprotein B48.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700329-JLR200

10.1194/JLR.M700329-JLR200

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017